To probe therapeutic avenues, we show that the cancer-sensitizing agent and CHEK1/2 dual inhibitor AZD7762 can prevent radiation- and chemotherapy-induced primordial oocyte elimination. This evidence concerns the gene CHEK1 and cancer.